Next Article in Journal
The Risk from Anti-Thyroid Hormone Antibody Interference in Neonatal Congenital Hypothyroidism Screening
Next Article in Special Issue
A Rare Case of Malonic Aciduria Diagnosed by Newborn Screening in Qatar
Previous Article in Journal
Fibroblast Fatty-Acid Oxidation Flux Assays Stratify Risk in Newborns with Presumptive-Positive Results on Screening for Very-Long Chain Acyl-CoA Dehydrogenase Deficiency
Previous Article in Special Issue
Newborn Screening for X-Linked Adrenoleukodystrophy
 
 
Review

Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned

Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, 12201-2002 NY, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Harvey L. Levy
Int. J. Neonatal Screen. 2017, 3(1), 3; https://doi.org/10.3390/ijns3010003
Received: 8 November 2016 / Revised: 12 February 2017 / Accepted: 12 February 2017 / Published: 1 March 2017
(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
Newborn screening (NBS) for Krabbe disease (KD) began in New York (NY) in August 2006. In summary, after eight years of screening there were five infants identified with early-onset Krabbe disease. Four underwent transplant, two are surviving with moderate to severe handicaps, and two died from transplant-related complications. An additional forty-six asymptomatic infants were found to be at moderate or high risk for disease. Screening for KD is both analytically and medically challenging; since screening for KD possesses both of these challenges, and many more, the lessons learned thus far could be used to predict the challenges that may be faced when screening for other lysosomal storage disorders (LSDs). This paper briefly reviews reports of NBS for LSDs from varied world programs. The challenges encountered in screening for KD in NY will be highlighted, and this experience, combined with hindsight, will inform what may be expected in the future as screening for LSDs expands. View Full-Text
Keywords: newborn screening; lysosomal storage disorders; Krabbe disease newborn screening; lysosomal storage disorders; Krabbe disease
MDPI and ACS Style

Orsini, J.J.; Caggana, M. Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned. Int. J. Neonatal Screen. 2017, 3, 3. https://doi.org/10.3390/ijns3010003

AMA Style

Orsini JJ, Caggana M. Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned. International Journal of Neonatal Screening. 2017; 3(1):3. https://doi.org/10.3390/ijns3010003

Chicago/Turabian Style

Orsini, Joseph J., and Michele Caggana. 2017. "Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned" International Journal of Neonatal Screening 3, no. 1: 3. https://doi.org/10.3390/ijns3010003

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop